Indications:
● Treatment of severe psoriasis, including plaque psoriasis, pustular psoriasis, and erythrodermic psoriasis.
● Management of other severe skin disorders as determined by a healthcare provider.
Administration Guidelines:
● Dosage: The dosage of Soriatane varies depending on the severity and type of skin condition, as well as the patient's response to the medication. Dosage adjustments may be necessary to find the optimal therapeutic effect with minimal side effects.
● Method of Administration: Administered orally, typically taken once daily with the main meal to enhance absorption.
● Soriatane is generally recommended for short-term use, although some patients might need longer therapy under close doctor supervision.
Dosage Forms:
● Capsules: Soriatane is available in capsule form to be taken orally, facilitating ease of use for ongoing management of psoriasis.
Safety Preclusions
Pregnancy and Breastfeeding:
● Soriatane is contraindicated during pregnancy and in women of childbearing potential who do not use reliable contraception during and for three years after the treatment due to the high risk of severe birth defects.
● Women must use effective contraception during treatment and continue it for three years after stopping treatment due to the drug's long half-life.
Long-term Use:
● Long-term use of Soriatane can cause potential side effects such as liver damage and increased levels of blood fats. Regular blood tests are necessary to monitor liver function and lipid levels.
● Patients should also monitor for signs of mood changes or depressive symptoms.
Drug Interactions:
● Caution is advised when used with other medications, particularly those metabolized by the liver or other drugs known to increase the toxicity of retinoids, such as tetracyclines.
|
Reviews
There are no reviews yet.